» Articles » PMID: 36398246

Genistein Promotes Apoptosis of Lung Cancer Cells Through the IMPDH2/AKT1 Pathway

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2022 Nov 18
PMID 36398246
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Lung cancer (LC) is a clinically challenging cancer. Genistein is a natural isoflavone product with anti-tumor effects. This study aims to investigate the effect of genistein on A549 cell apoptosis, to provide more experimental evidence for clinical treatment.

Methods: Real-time quantitative polymerase chain reaction, western blotting, molecular docking, and target prediction methods were performed to detect the effect of genistein on LC cells. Cell viability of A549 treated by genistein was measured by a CCK-8 assay. The A549 cell apoptosis after genistein treatment was detected by flow cytometry.

Results: Genistein promoted the apoptosis of LC cells in a time- and concentration-dependent manner. In addition, the low expression of inosine monophosphate dehydrogenase-2 (IMPDH2) inhibited the effect of genistein on LC cells. By predicting IMPDH2 LC-related apoptosis genes and finding the closely related gene protein kinase B (AKT1), it was found that the highly expressed AKT1 inhibited the effect of genistein on LC cell apoptosis and viability.

Conclusion: Genistein may be a promising treatment for LC.

Citing Articles

Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions.

Vithalkar M, Pradhan S, Sandra K, Bharath H, Nayak Y Cell Biochem Biophys. 2025; .

PMID: 39966334 DOI: 10.1007/s12013-025-01696-4.


Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies.

Lekhak N, Bhattarai H Cancer Control. 2024; 31:10732748241302902.

PMID: 39629692 PMC: 11615997. DOI: 10.1177/10732748241302902.


Potential Anticancer Effects of Isoflavone Prunetin and Prunetin Glycoside on Apoptosis Mechanisms.

Jeong S, Kim H, Park M, Bhosale P, Abusaliya A, Hwang K Int J Mol Sci. 2024; 25(21).

PMID: 39519265 PMC: 11545868. DOI: 10.3390/ijms252111713.


Bio-Inspired Nanodelivery Platform: Platelet Membrane-Cloaked Genistein Nanosystem for Targeted Lung Cancer Therapy.

Gao R, Lin P, Yang W, Fang Z, Gao C, Cheng B Int J Nanomedicine. 2024; 19:10455-10478.

PMID: 39430311 PMC: 11491070. DOI: 10.2147/IJN.S479438.


Identifying the Multitarget Pharmacological Mechanism of Action of Genistein on Lung Cancer by Integrating Network Pharmacology and Molecular Dynamic Simulation.

Das R, Woo J Molecules. 2024; 29(9).

PMID: 38731403 PMC: 11085736. DOI: 10.3390/molecules29091913.


References
1.
Huang W, Wan C, Luo Q, Huang Z, Luo Q . Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer. Int J Mol Sci. 2014; 15(3):3432-43. PMC: 3975346. DOI: 10.3390/ijms15033432. View

2.
Collart F, Chubb C, Mirkin B, Huberman E . Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res. 1992; 52(20):5826-8. DOI: 10.2172/10148922. View

3.
Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A . Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem. 2011; 112(9):2296-306. PMC: 3155646. DOI: 10.1002/jcb.23150. View

4.
Jackson R, Weber G, MORRIS H . IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature. 1975; 256(5515):331-3. DOI: 10.1038/256331a0. View

5.
Colby T, Vanderveen K, Strickler M, Markham G, Goldstein B . Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Proc Natl Acad Sci U S A. 1999; 96(7):3531-6. PMC: 22327. DOI: 10.1073/pnas.96.7.3531. View